Physician profile
Ramesh Luther
NPI 1437141991
$2,896.56
in general payments reported to CMS, 2019-2025
13 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $841 · 2020: $193 · 2021: $365 · 2022: $609 · 2023: $380 · 2024: $374 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $888.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,140.44 | 2019-2025 | |
| Janssen Biotech, INC. | $636.56 | 2019-2022 | |
| Cook Medical LLC | $254.73 | 2019-2023 | Hemospray |
| Takeda Pharmaceuticals U.S.A., INC. | $211.18 | 2019-2023 | Gattex |
| Pfizer INC. | $184.62 | 2019-2025 | |
| Celgene Corporation | $134.70 | 2021-2023 | Zeposia |
| Mallinckrodt Enterprises LLC | $109.44 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $87.63 | 2019-2023 | Trulance |
| Braintree Laboratories, INC. | $40.62 | 2019-2021 | |
| Fujifilm Healthcare Americas Corporation | $37.60 | 2022-2024 | Fujifilm |
| Daiichi Sankyo INC. | $22.67 | 2019 | |
| Gilead Sciences, INC. | $21.20 | 2024 | |
| Endo Pharmaceuticals INC. | $15.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramesh Luther listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.